HUM Stock Summary and Trading Ideas (Humana | NYSE:HUM)

Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Humana trades on the NYSE stock market under the symbol HUM.

As of February 7, 2025, HUM stock price declined to $274.33 with 943,294 million shares trading.

HUM has a market cap of $33.06 billion. This is considered a Large Cap stock.

Last quarter Humana reported $29 billion in Revenue and $4.16 earnings per share. This beat revenue expectation by $630 million and exceeded earnings estimates by $.76.

In the last 3 years, HUM traded as high as $571.30 and as low as $213.31.

The top ETF exchange traded funds that HUM belongs to (by Net Assets): VTI, VOO, SPY, IVV, VO.

HUM has underperformed the market in the last year with a price return of -24.6% while the SPY ETF gained +22.0%. HUM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -4.4% and -6.9%, respectively, while the SPY returned +1.2% and -1.2%, respectively.

HUM support price is $272.55 and resistance is $286.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HUM shares will trade within this expected range on the day.